Tag: #Global Trends

Key Development Forge Biologics, a member of Ajinomoto Bio-Pharma Services, has entered a development and cGMP manufacturing partnership with Restore... Read more

Key Development Amgen has agreed to pay US$74 million to settle a shareholder class-action lawsuit alleging that the biotechnology company... Read more

Key Development The U.S. Food and Drug Administration (FDA) has launched a pilot program designed to encourage domestic manufacturing of... Read more

Key Development The exclusive commercial partnership between PolyPid and Azurity Pharmaceuticals marks more than a regional licensing agreement it reflects... Read more

Key Development A temporary pause in selected Medicaid payments to California has brought renewed attention to one of the most... Read more

Key Development Competition in the obesity and diabetes market has entered a new phase where legal strategy is becoming as... Read more

Key Development NHS England has officially issued routine commissioning approvals for two specialized rare blood cancer therapies: Novartis’ Tafinlar® (dabrafenib)... Read more

Key Development Samsung Biologics has announced an all-cash acquisition offer valued at approximately CHF 1.46 billion (US$1.8 billion) for Swiss-based... Read more

Key Development Novartis is entering one of the most consequential periods in its post-transformation strategy. While the company continues to... Read more